UBS AG / Key word(s): Bond 17.12.2015 07:00 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- 17 December 2015 News Release UBS announces successful completion of public tender offer UBS has accepted for repurchase certain of its senior and subordinated debt and covered bonds in an aggregate principal amount of approximately CHF 6.1 billion. Zurich/Basel, 17 December 2015 - UBS announces the successful completion of the cash tender offers, announced on 4 December 2015, to re-purchase 17 issues of its senior, subordinated debt and covered bonds with an aggregate principal amount equivalent to approximately CHF 16 billion. 14 securities with an aggregate principal amount equivalent to approximately CHF 6.1 billion were accepted. This transaction is consistent with our proactive approach to optimizing the Group's interest expense, while maintaining our strong liquidity, funding and capital position. We expect to record an expense in the fourth quarter of 2015 related to this transaction of approximately CHF 272 million, which will be recognized as negative other income within Corporate Center - Group Asset and Liability Management and will be treated as an adjusting item in determining the Group's adjusted operating profit/ (loss) before tax. We expect to recover the expense incurred in approximately 1.6 years primarily through reduction of future interest expense from the purchased bonds. The repurchase of the bonds is expected to have an immaterial effect on our CET1 ratio, however the transaction will reduce our BIS Basel III phase-in total capital by approximately CHF 658 million. Some of the subordinated bonds repurchased are currently eligible as Tier 2 under the BIS Basel III phase-in rules, but will not be eligible for Tier 2 capital treatment on a fully-applied basis beginning in 2019 and are not expected to be eligible as loss absorbing capacity under the anticipated revisions to the Swiss "too-big-to-fail" regulation. UBS AG Investor contact Switzerland: +41-44-234 41 00 Media contact Switzerland: +41-44-234 85 00 UK: +44-207-567 47 14 Americas: +1-212-882 58 57 APAC: +852-297-1 82 00 www.ubs.com Cautionary Statement Regarding Forward-Looking Statements This release contains statements that constitute "forward-looking statements". While these statements represent UBS's expectation concerning future developments, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from UBS's expectations. In addition, these results could depend on other factors that we have previously indicated could affect our business and financial performance which are contained in our past and future filings and reports, including those filed with the SEC. More detailed information about those factors is set forth in documents furnished by UBS and filings made by UBS with the SEC, including UBS's Annual Report on Form 20-F for the year ended 31 December 2014. UBS is not under any obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. 17.12.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: UBS AG Bahnhofstrasse 45 8001 Zürich Switzerland Phone: +41 44 234 11 11 Fax: E-mail: info@ubs.com Internet: www.ubs.com ISIN: CH0024899483, CH0039913899 WKN: UB0BL6 Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart; Open Market in Frankfurt ; SIX End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: UBS AG: UBS announces successful completion of
Top 10 Most Recent News Articles
Miami Backyard Ultra: Runners Face Ultimate Test
A New Challenge for Miami's Running Scene Mark the date: December 19, 2026. Miami is about to dive headfirst into the madness of the backyard ultra scene. At 8 AM sharp, the inaugural Miami Backyard Ultra kicks off at the Miami Marine Stadium & Basin Trail on Virginia Key, promising a grueling, yet thrilling, test of endurance. It’s like this city’s stepping up with...
Continue Reading
Travel Deal Tuesday Offers Major Savings Opportunities
Travel aficionados, pay attention! Hopper's Travel Deal Tuesday is back, and if there's any day to catch a break on your jet-setting costs, it's December 1st. Travel costs have been on a steep incline, with domestic airfares up a whopping 40% over the past year. This year marks the tenth anniversary of Travel Deal Tuesday, and Hopper is pulling out all the stops to save...
Continue Reading
Universal Music CFO to Speak at Major Tech Conference
UMG Steps into the Spotlight at Morgan Stanley Event Music, money, and technology—it's a compelling trio. Universal Music Group (EURONEXT: UMG) is sending its heavyweights, Matt Ellis and Michael Nash, to the Morgan Stanley European Technology, Media & Telecom Conference on November 18, 2026. This isn't just any run-of-the-mill industry hobnob. We're talking about the...
Continue Reading
Raytron Dominates Global Thermal Imaging Market in 2026
Raytron's Market Supremacy: By the Numbers If you're looking at the thermal imaging sector and wondering what's what, take a clue from Raytron. This outfit isn't just playing the game—it's running the show with a staggering 30% of the global market in 2025. That's right, they hold the medal for leading global shipments in thermal imaging, and unlike many industries...
Continue Reading
Premium Guard Inc. Secures 2027 Top Supplier Honor
This ain't your everyday pat on the back—when Premium Guard Inc. (PGI) snagged the 2027 Top Supplier title from MEMA Aftermarket Suppliers and aftermarketNews, it was a nod to their hustle in the wild world of automotive. Yeah, the guys in Memphis are overachievers, consistently nudging the envelope of car parts. Why Premium Guard Stands Out Let’s be real, it’s not...
Continue Reading
Jing'an District Drives Bold Investments at 2026 CIIE
Jing'an's Strategic Moves at 2026 CIIE When you hear "Shanghai," you probably think bright lights, bustling streets, and a city that never sleeps. Now narrow that down even further and you get Jing'an District—a place that's climbing the ladder not just in glitz, but in strategic moves that matter. This year, during the China International Import Expo (CIIE), Jing'an...
Continue Reading
Gilbert Welcomes Luxury Florals: French Florist Expands
A Fresh Bloom in Gilbert: French Florist Steps In Toss aside your preconceived notions of what a florist shop should be. When French Florist sets up shop, it's not just about selling flowers—they’re a game-changer in the floral industry. As of November 4, they've stamped their luxury mark in Gilbert, Arizona, courtesy of Ronny and Nicole Record, who aren’t your...
Continue Reading
Day Out Snacks Brings Back Sold-Out Peppermint Bark
Spicing Up the Holidays with a Best-Seller Return You've got to love when a brand nails it in the holiday treat department, and Day Out Snacks is playing a winning hand by bringing back their Peppermint Bark protein balls. Here we are again, one year after they flew off the shelves like Santa spotted on Christmas Eve. And let me tell you, this re-release has the potential...
Continue Reading
COP31 Highlights: Energy Transition's Role in Competition
Energy Transition: The New Competitive Edge Forget everything you thought you knew about energy as just a line item in an industry ledger. At the heart of the ongoing COP31 gathering in Antalya, Türkiye, is the revelation that energy has morphed into something greater—it's become the battleground for global competitive advantage. Ali Y. Koç didn't mince words when he...
Continue Reading
Envista's $430M Senior Notes: A Market Move Decoded
Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...
Continue ReadingTop 5 Most Recently Viewed Articles
Veterans Find Community and Wellness at Orland Hills Bash
A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...
Continue Reading
Investors Alert: Join the Fiserv, Inc. Class Action Now
Investors Unite: Important News About Fiserv, Inc. National plaintiffs' law firm Berger Montague is launching an investigation into potential claims against Fiserv, Inc. (NYSE: FI). This inquiry is prompted by allegations of serious securities law violations pertaining to the company's recent business practices. Investors must be informed and proactive about their rights...
Continue Reading
HanAll Biopharma's Batoclimab Receives Orphan Drug Designation
HanAll Biopharma's Batoclimab Receives Orphan Drug Designation In a significant development, Batoclimab has achieved Orphan Drug Designation status, a crucial advancement in the treatment landscape for active Thyroid Eye Disease (TED). This pioneering therapy will enhance accessibility and convenience for patients, allowing them the potential to self-administer the...
Continue Reading
Revolutionizing Mental Health: atai Life Sciences' VLS-01 Update
atai Life Sciences Celebrates Milestone in Mental Health Treatment In a significant advancement for mental health treatment, atai Life Sciences has announced that the first patient has been dosed in its Phase 2 clinical trial, Elumina. This trial focuses on VLS-01, a groundbreaking buccal film formulation of N,N-Dimethyltryptamine (DMT), aimed at providing relief for...
Continue Reading
Shell plc's Recent Share Buyback Initiative Explained
Shell plc Announces Share Buyback News Shell plc, a leading energy company, recently announced a significant move regarding its shares. This initiative involves the purchase of its own shares for cancellation, underscoring the company's commitment to enhancing shareholder value. Details of the Share Purchase During this buyback, Shell purchased a total of 900,000 shares...
Continue Reading